A living biobank of breast cancer organoids captures disease heterogeneity

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106 · see citing works

Fast and accurate short read alignment with Burrows-Wheeler transform

Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607 · see citing works

STAR: ultrafast universal RNA-seq aligner

Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709 · see citing works

The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data

McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895 · see citing works

HTSeq—a Python framework to work with high-throughput sequencing data

Anders, S., Pyl, P. T., & Huber, W. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu638 · Cited by 21,464 · see citing works

Comprehensive molecular portraits of human breast tumours

The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129 · see citing works

A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w ¹¹¹⁸ ; iso-2; iso-3

Cingolani, P., Platts, A., Wang, L. L., Coon, M., Nguyen, T., Wang, L., Land, S. J., Lu, X., & Ruden, D. M. (2012) · Fly · doi:10.4161/fly.19695 · Cited by 11,816 · see citing works

Signatures of mutational processes in human cancer

Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660 · see citing works

Adjusting batch effects in microarray expression data using empirical Bayes methods

Johnson, W. E., Li, C., & Rabinovic, A. (2007) · Biostatistics · doi:10.1093/biostatistics/kxj037 · Cited by 8,658 · see citing works

dbSNP: the NCBI database of genetic variation

Sherry, S. T. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.1.308 · Cited by 7,502 · see citing works

Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche

Sato, T., Vries, R. G., Snippert, H. J., van de Wetering, M., Barker, N., Stange, D. E., van Es, J. H., Abo, A., Kujala, P., Peters, P. J., et al. (2009) · Nature · doi:10.1038/nature07935 · Cited by 7,204 · see citing works

From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline

Van der Auwera, G. A., Carneiro, M. O., Hartl, C., Poplin, R., del Angel, G., Levy‐Moonshine, A., Jordan, T., Shakir, K., Roazen, D., Thibault, J., et al. (2013) · Current Protocols in Bioinformatics · doi:10.1002/0471250953.bi1110s43 · Cited by 6,687 · see citing works

pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up

Elston, C. W., & Ellis, I. O. (1991) · Histopathology · doi:10.1111/j.1365-2559.1991.tb00229.x · Cited by 6,181 · see citing works

Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples

Cibulskis, K., Lawrence, M. S., Carter, S. L., Sivachenko, A., Jaffe, D. B., Sougnez, C. L., Gabriel, S., Meyerson, M. M., Lander, E. S., & Getz, G. A. (2013) · Nature Biotechnology · doi:10.1038/nbt.2514 · Cited by 4,838 · see citing works

VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencingPreprint

Koboldt, D. C., Zhang, Q., Larson, D. E., Shen, D., McLellan, M. D., Lin, L., Miller, C. A., Mardis, E. R., Ding, L., & Wilson, R. K. (2012) · Genome Research · doi:10.1101/gr.129684.111 · Cited by 4,822 · see citing works

Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes

Parker, J. S., Mullins, M., Cheang, M. C. U., Leung, S. C. Y., Voduc, D. K., Vickery, T. L., Davies, S. R., Fauron, C. M. ‐., He, X., Hu, Z., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.1370 · Cited by 4,737 · see citing works

Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt

Durinck, S., Spellman, P. T., Birney, E., & Huber, W. K. (2009) · Nature Protocols · doi:10.1038/nprot.2009.97 · Cited by 4,081 · see citing works

Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett’s epithelium

Sato, T., Stange, D. E., Ferrante, M., Vries, R. G. J., van Es, J. H., van den Brink, S., van Houdt, W. J., Pronk, A., van Gorp, J., Siersema, P. D., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.050 · Cited by 3,753 · see citing works

Haplotype-based variant detection from short-read sequencing

Garrison, E., & Marth, G. (2012) · arXiv · doi:10.48550/arxiv.1207.3907 · Cited by 3,700 · see citing works

Modeling Development and Disease with Organoids

Clevers, H. (2016) · Cell · doi:10.1016/j.cell.2016.05.082 · Cited by 3,196 · see citing works

Large-scale gene function analysis with the PANTHER classification system

Mi, H., Muruganujan, A., Casagrande, J. T., & Thomas, P. D. (2013) · Nature Protocols · doi:10.1038/nprot.2013.092 · Cited by 2,422 · see citing works

Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients

van de Wetering, M., Francies, H. E., Francis, J. M., Bounova, G., Iorio, F., Pronk, A., van Houdt, W., van Gorp, J., Taylor-Weiner, A., Kester, L., et al. (2015) · Cell · doi:10.1016/j.cell.2015.03.053 · Cited by 2,408 · see citing works

Landscape of somatic mutations in 560 breast cancer whole-genome sequences

Nik-Zainal, S., Davies, H., Staaf, J., Ramakrishna, M., Glodzik, D., Zou, X., Martincorena, I., Alexandrov, L. B., Martin, S., Wedge, D. C., et al. (2016) · Nature · doi:10.1038/nature17676 · Cited by 2,218 · see citing works

Organoid models of human and mouse ductal pancreatic cancer

Boj, S. F., Hwang, C.-I., Baker, L. A., Chio, I. I. C., Engle, D. D., Corbo, V., Jager, M., Ponz-Sarvise, M., Tiriac, H., Spector, M. S., et al. (2015) · Cell · doi:10.1016/j.cell.2014.12.021 · Cited by 2,150 · see citing works

Mutational Processes Molding the Genomes of 21 Breast Cancers

Nik-Zainal, S., Alexandrov, L. B., Wedge, D. C., Van Loo, P., Greenman, C. D., Raine, K., Jones, D., Hinton, J., Marshall, J., Stebbings, L. A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.024 · Cited by 1,909 · see citing works

Pan-cancer patterns of somatic copy number alteration

Zack, T. I., Schumacher, S. E., Carter, S. L., Cherniack, A. D., Saksena, G., Tabak, B., Lawrence, M. S., Zhang, C., Wala, J. A., Mermel, C. H., et al. (2013) · Nature Genetics · doi:10.1038/ng.2760 · Cited by 1,843 · see citing works

Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer

Ciriello, G., Gatza, M. L., Beck, A. H., Wilkerson, M. D., Rhie, S. K., Pastore, A., Zhang, H., McLellan, M. D., Yau, C. S. F., Kandoth, C., et al. (2015) · Cell · doi:10.1016/j.cell.2015.09.033 · Cited by 1,836 · see citing works

The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes

Pereira, B., Chin, S., Rueda, O. M., Vollan, H. K. M., Provenzano, E., Bardwell, H. A., Pugh, M., Jones, L. R., Russell, R., Sammut, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms11479 · Cited by 1,712 · see citing works

Strelka: accurate somatic small-variant calling from sequenced tumor–normal sample pairs

Saunders, C. T., Wong, W. S. W., Swamy, S., Becq, J., Murray, L. J., & Cheetham, R. K. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts271 · Cited by 1,589 · see citing works

Organoid Cultures Derived from Patients with Advanced Prostate Cancer

Gao, D., Vela, I., Sboner, A., Iaquinta, P. J., Karthaus, W. R., Gopalan, A., Dowling, C., Wanjala, J. N., Undvall, E. A., Arora, V. K., et al. (2014) · Cell · doi:10.1016/j.cell.2014.08.016 · Cited by 1,559 · see citing works

Choosing the right cell line for breast cancer research

Holliday, D. L., & Speirs, V. (2011) · Breast Cancer Research · doi:10.1186/bcr2889 · Cited by 1,548 · see citing works

WHO classification of tumours of the breast

Lakhani, S. R., Ellis, I. O., Schnitt, S. J., et al. (2012) · International Agency for Research on Cancer eBooks · Cited by 1,522 · see citing works

Somatic mutation in cancer and normal cells

Martincorena, I., & Campbell, P. J. (2015) · Science · doi:10.1126/science.aab4082 · Cited by 1,396 · see citing works

High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response

Gao, H., Korn, J. M., Ferretti, S., Monahan, J. E., Wang, Y., Singh, M., Zhang, C., Schnell, C., Yang, G., Zhang, Y., et al. (2015) · Nature Medicine · doi:10.1038/nm.3954 · Cited by 1,393 · see citing works

The ErbB/HER family of protein-tyrosine kinases and cancer

Roskoski, R. J. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.11.002 · Cited by 1,365 · see citing works

Three-dimensional culture models of normal and malignant breast epithelial cells

Lee, G. Y., Kenny, P. A., Lee, E. H., & Bissell, M. J. (2007) · Nature Methods · doi:10.1038/nmeth1015 · Cited by 1,336 · see citing works

Sequence analysis of mutations and translocations across breast cancer subtypes

Banerji, S. O., Cibulskis, K., Rangel‐Escareño, C., Brown, K., Carter, S. L., Frederick, A. M., Lawrence, M. S., Sivachenko, A., Sougnez, C. L., Zou, L., et al. (2012) · Nature · doi:10.1038/nature11154 · Cited by 1,181 · see citing works

Sequential cancer mutations in cultured human intestinal stem cells

Drost, J., van Jaarsveld, R. H., Ponsioen, B., Zimberlin, C., van Boxtel, R., Buijs, A., Sachs, N., Overmeer, R. M., Offerhaus, G. J., Begthel, H., et al. (2015) · Nature · doi:10.1038/nature14415 · Cited by 1,067 · see citing works

Control-FREEC: a tool for assessing copy number and allelic content using next-generation sequencing data

Boeva, V., Popova, T. G., Kevin Bleakley, A., Chiche, P., Cappo, J., Schleiermacher, G., Janoueix‐Lerosey, I., Delattre, O., & Barillot, E. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr670 · Cited by 1,012 · see citing works

Tissue-specific mutation accumulation in human adult stem cells during life

Blokzijl, F., de Ligt, J., Jager, M., Sasselli, V., Roerink, S., Sasaki, N., Huch, M., Boymans, S., Kuijk, E., Prins, P., et al. (2016) · Nature · doi:10.1038/nature19768 · Cited by 935 · see citing works

Sustained in vitro intestinal epithelial culture within a Wnt-dependent stem cell niche

Ootani, A., Li, X., Sangiorgi, E., Ho, Q. T., Ueno, H., Toda, S., Sugihara, H., Fujimoto, K., Weissman, I. L., Capecchi, M. R., et al. (2009) · Nature Medicine · doi:10.1038/nm.1951 · Cited by 906 · see citing works

A Colorectal Tumor Organoid Library Demonstrates Progressive Loss of Niche Factor Requirements during Tumorigenesis

Fujii, M., Shimokawa, M., Date, S., Takano, A., Matano, M., Nanki, K., Ohta, Y., Toshimitsu, K., Nakazato, Y., Kawasaki, K., et al. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.04.003 · Cited by 852 · see citing works

Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes

Desmedt, C., Haibe‐Kains, B., Wirapati, P., Buyse, M. E., Larsimont, D., Bontempi, G., Delorenzi, M., Piccart, M. J., & Sotiriou, C. P. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4756 · Cited by 827 · see citing works

BoxPlotR: a web tool for generation of box plots

Spitzer, M., Wildenhain, J., Rappsilber, J., & Tyers, M. (2014) · Nature Methods · doi:10.1038/nmeth.2811 · Cited by 809 · see citing works

ROCK Inhibitor and Feeder Cells Induce the Conditional Reprogramming of Epithelial Cells

Liu, X., Ory, V., Chapman, S., Yuan, H., Albanese, C., Kallakury, B., Timofeeva, O. A., Nealon, C., Dakic, A., Simic, V., et al. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.10.036 · Cited by 726 · see citing works

Problems in Breast Pathology

CARTER, D. (1980) · Archives of Surgery · doi:10.1001/archsurg.1980.01380110136028 · Cited by 700 · see citing works

Problems in Breast Pathology

Azzopardi, J. G., Ahmed, A., & Millis, R. R. (2006) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-006-0138-0 · Cited by 698 · see citing works

Modelling breast cancer: one size does not fit all

Vargo-Gogola, T. C., & Rosen, J. M. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2193 · Cited by 681 · see citing works

Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents

Sharma, S. V., Haber, D. A., & Settleman, J. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2820 · Cited by 585 · see citing works

Role of the Tumor Microenvironment in Breast Cancer

Soysal, S. D., Tzankov, A., & Muenst, S. E. (2015) · Pathobiology · doi:10.1159/000430499 · Cited by 511 · see citing works

Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long‐term follow‐up

Ellis, I. O., Galea, M., BROUGHTON, N., Locker, A. P., Blamey, R. W., & Elston, C. W. (1992) · Histopathology · doi:10.1111/j.1365-2559.1992.tb01032.x · Cited by 486 · see citing works

Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes

Dai, X., Xiang, L., Li, T., & Bai, Z. (2016) · Journal of Cancer · doi:10.7150/jca.13141 · Cited by 439 · see citing works

A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds

Bruna, A., Rueda, O. M., Greenwood, W., Batra, A. S., Callari, M., Batra, R. N., McNamara, K. L., Sandoval, J. L., Cassidy, J. W., Vidaković, A. T., et al. (2016) · Cell · doi:10.1016/j.cell.2016.08.041 · Cited by 432 · see citing works

Genefu: an R/Bioconductor package for computation of gene expression-based signatures in breast cancer

Gendoo, D. M. A., Ratanasirigulchai, N., Schröder, M., Paré, L., Parker, J. S., Prat, A., & Haibe‐Kains, B. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv693 · Cited by 389 · see citing works

Organoid cultures for the analysis of cancer phenotypes

Sachs, N., & Clevers, H. C. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.11.012 · Cited by 373 · see citing works

PARP Inhibitors for BRCA1/2 mutation-associated and BRCA-like malignancies

Lee, J.-M., Ledermann, J. A., & Kohn, E. C. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt384 · Cited by 352 · see citing works

A Three-Gene Model to Robustly Identify Breast Cancer Molecular Subtypes

Haibe‐Kains, B., Desmedt, C., Loi, S., Culhane, A. C., Bontempi, G., Quackenbush, J. F., & Sotiriou, C. P. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr545 · Cited by 313 · see citing works

Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland.

Yang, Y., Spitzer, E., Meyer, D., et al. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.131.1.215 · Cited by 300 · see citing works

Patient-derived xenograft models of breast cancer and their predictive power

Whittle, J. R., Lewis, M. T., Lindeman, G. J., & Visvader, J. E. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0523-1 · Cited by 280 · see citing works

Targeting mutant RAS in patient-derived colorectal cancer organoids by combinatorial drug screening

Verissimo, C. S., Overmeer, R. M., Ponsioen, B., Drost, J., Mertens, S., Verlaan-Klink, I., Gerwen, B. V., van der Ven, M., Wetering, M. V. D., Egan, D. A., et al. (2016) · eLife · doi:10.7554/elife.18489 · Cited by 263 · see citing works

Genome-driven integrated classification of breast cancer validated in over 7,500 samples

Ali, H. R., Rueda, O. M., Chin, S., Curtis, C. N., Dunning, M., Aparicio, S. A. J. R., & Caldas, C. (2014) · Genome biology · doi:10.1186/s13059-014-0431-1 · Cited by 224 · see citing works

Fixing problems with cell lines

Lorsch, J. R., Collins, F. S., & Lippincott-Schwartz, J. (2014) · Science · doi:10.1126/science.1259110 · Cited by 179 · see citing works

Emerging targeted agents in metastatic breast cancer

Zardavas, D., Baselga, J. M., & Piccart, M. J. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.29 · Cited by 177 · see citing works

SnapShot: Growing Organoids from Stem Cells

Sato, T., & Clevers, H. (2015) · Cell · doi:10.1016/j.cell.2015.06.028 · Cited by 168 · see citing works

Revisiting tumour aneuploidy — the place of ploidy assessment in the molecular era

Danielsen, H. E., Pradhan, M., & Novelli, M. R. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.208 · Cited by 161 · see citing works

Lobular breast cancer: Clinical, molecular and morphological characteristics

Christgen, M., Steinemann, D., Kühnle, E., et al. (2016) · Pathology - Research and Practice · doi:10.1016/j.prp.2016.05.002 · Cited by 160 · see citing works

Use of Three-Dimensional Basement Membrane Cultures to Model Oncogene-Induced Changes in Mammary Epithelial Morphogenesis

Shaw, K. R. M., Wrobel, C. N., & Brugge, J. S. (2004) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-004-1402-z · Cited by 149 · see citing works

Regulation of Mouse Mammary Gland Development and Tumorigenesis by the ERBB Signaling Network

Troyer, K. L., & Lee, D. C. (2001) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1009560330359 · Cited by 114 · see citing works

Removing batch effects from purified plasma cell gene expression microarrays with modified ComBat

Stein, C. K., Qu, P., Epstein, J., Buros, A. F., Rosenthal, A., Crowley, J. J., Morgan, G. J., & Barlogie, B. (2015) · BMC Bioinformatics · doi:10.1186/s12859-015-0478-3 · Cited by 100 · see citing works

The impact of lobular and ductal breast cancer histology on the metastatic behavior and long term survival of breast cancer patients

Korhonen, T., Kuukasjärvi, T., Huhtala, H., et al. (2013) · The Breast · doi:10.1016/j.breast.2013.06.001 · Cited by 91 · see citing works

Organoids as Models for Neoplastic Transformation

Neal, J. T., & Kuo, C. J. (2016) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044249 · Cited by 85 · see citing works

Wet medisch-wetenschappelijk onderzoek met mensen

Beerepoot, C. C., van Donk, R. N., Hermans, H. E. G. M. C., & Linders, J. J. M. (2010) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-8820-2_33 · Cited by 59 · see citing works

Dynamic Expression of Erbb Pathway Members during Early Mammary Gland Morphogenesis

Wansbury, O., Panchal, H., James, M., Parry, S., Ashworth, A., & Howard, B. A. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701118 · Cited by 34 · see citing works

Intrinsic Subtypes of Primary Breast Cancer - Gene Expression Analysis

Schmidt, M., Thomssen, C., & Untch, M. (2016) · Oncology Research and Treatment · doi:10.1159/000444409 · Cited by 20 · see citing works

The Actual Role of Receptors as Cancer Markers, Biochemical and Clinical Aspects: Receptors in Breast Cancer

Brennan, M., & Lim, B. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-94-017-7215-0_20 · Cited by 20 · see citing works

Concepts of extracellular matrix remodelling in tumour progression and metastasis

Winkler, J., Abisoye-Ogunniyan, A., Metcalf, K. J., & Werb, Z. (2020) · Nature Communications · doi:10.1038/s41467-020-18794-x · Cited by 2,296 · see citing works

Human organoids: model systems for human biology and medicine

Kim, J., Koo, B.-K., & Knoblich, J. A. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0259-3 · Cited by 2,187 · see citing works

Organoids in cancer research

Drost, J., & Clevers, H. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0007-6 · Cited by 1,790 · see citing works

Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis

Feng, Y., Spezia, M., Huang, S., Yuan, C., Zeng, Z., Zhang, L., Ji, X., Liu, W., Huang, B., Luo, W., et al. (2018) · Genes & Diseases · doi:10.1016/j.gendis.2018.05.001 · Cited by 1,537 · see citing works

Progress and potential in organoid research

Rossi, G., Manfrin, A., & Lutolf, M. P. (2018) · Nature Reviews Genetics · doi:10.1038/s41576-018-0051-9 · Cited by 1,182 · see citing works

Engineering organoids

Hofer, M., & Lutolf, M. P. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00279-y · Cited by 1,184 · see citing works

A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity

Jacob, F., Salinas, R. D., Zhang, D. Y., Nguyen, P. T. T., Schnoll, J. G., Wong, S. Z. H., Thokala, R., Sheikh, S., Saxena, D., Prokop, S., et al. (2020) · Cell · doi:10.1016/j.cell.2019.11.036 · Cited by 1,149 · see citing works

Organoids

Zhao, Z., Chen, X., Dowbaj, A. M., Sljukic, A., Bratlie, K., Lin, L., Fong, E. L. S., Balachander, G. M., Chen, Z., Soragni, A., et al. (2022) · Nature Reviews Methods Primers · doi:10.1038/s43586-022-00174-y · Cited by 1,001 · see citing works

Cancer modeling meets human organoid technology

Tuveson, D., & Clevers, H. (2019) · Science · doi:10.1126/science.aaw6985 · Cited by 935 · see citing works

Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer

Lee, S. H., Hu, W., Matulay, J. T., Silva, M. V., Owczarek, T. B., Kim, K., Chua, C. W., Barlow, L. J., Kandoth, C., Williams, A. B., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.017 · Cited by 873 · see citing works

An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity

Kopper, O., de Witte, C. J., Lõhmussaar, K., Valle-Inclan, J. E., Hami, N., Kester, L., Balgobind, A. V., Korving, J., Proost, N., Begthel, H., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0422-6 · Cited by 834 · see citing works

Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening

Kim, M., Mun, H., Sung, C. O., Cho, E. J., Jeon, H.-J., Chun, S.-M., Jung, D. J., Shin, T. H., Jeong, G. S., Kim, D. K., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11867-6 · Cited by 812 · see citing works

Targeted therapy for hepatocellular carcinoma

Huang, A., Yang, X., Chung, W. Y., Dennison, A. R., & Zhou, J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00264-x · Cited by 750 · see citing works

Patient-Derived Organoids Predict Chemoradiation Responses of Locally Advanced Rectal Cancer

Yao, Y., Xu, X., Yang, L., Zhu, J., Wan, J., Shen, L., Xia, F., Fu, G., Deng, Y., Pan, M., et al. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2019.10.010 · Cited by 755 · see citing works

Lost in translation: the valley of death across preclinical and clinical divide – identification of problems and overcoming obstacles

Seyhan, A. A. (2019) · Translational Medicine Communications · doi:10.1186/s41231-019-0050-7 · Cited by 731 · see citing works

Establishment of patient-derived cancer organoids for drug-screening applications

Driehuis, E., Kretzschmar, K., & Clevers, H. C. (2020) · Nature Protocols · doi:10.1038/s41596-020-0379-4 · Cited by 656 · see citing works

Stem cell fate in cancer growth, progression and therapy resistance

Lytle, N. K., Barber, A. G., & Reya, T. (2018) · Nature reviews. Cancer · doi:10.1038/s41568-018-0056-x · Cited by 645 · see citing works

High-resolution 3D imaging of fixed and cleared organoids

Dekkers, J. F., Alieva, M., Wellens, L. M., Ariese, H. C., Jamieson, P. R., Vonk, A. M., Amatngalim, G. D., Hu, H., Oost, K. C., Snippert, H. J. G., et al. (2019) · Nature Protocols · doi:10.1038/s41596-019-0160-8 · Cited by 534 · see citing works

A brief history of organoids

Corrò, C., Novellasdemunt, L., & Li, V. S. W. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00120.2020 · Cited by 561 · see citing works

Human Organoids: Tools for Understanding Biology and Treating Diseases

Schutgens, F., & Clevers, H. C. (2019) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012419-032611 · Cited by 506 · see citing works

Patient-derived organoids from endometrial disease capture clinical heterogeneity and are amenable to drug screening

Boretto, M., Maenhoudt, N., Luo, X., Hennes, A., Boeckx, B., Bui, B. N., Heremans, R., Perneel, L., Kobayashi, H., Zundert, I. V., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0360-z · Cited by 507 · see citing works

Human organoids in basic research and clinical applications

Tang, X., Wu, S., Wang, D., Chu, C., Hong, Y., Tao, M., Hu, H., Xu, M., Guo, X., & Liu, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01024-9 · Cited by 424 · see citing works

Organoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies

Nuciforo, S., Fofana, I., Matter, M. S., Blumer, T., Calabrese, D., Boldanova, T., Piscuoglio, S., Wieland, S., Ringnalda, F., Schwank, G., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.07.001 · Cited by 473 · see citing works

Organoid and Spheroid Tumor Models: Techniques and Applications

Gunti, S., Hoke, A. T. K., Vu, K., & London, N. R. (2021) · Cancers · doi:10.3390/cancers13040874 · Cited by 492 · see citing works

High-Throughput Screening Enhances Kidney Organoid Differentiation from Human Pluripotent Stem Cells and Enables Automated Multidimensional Phenotyping

Czerniecki, S. M., Cruz, N. M., Harder, J. L., Menon, R., Annis, J., Otto, E. A., Gulieva, R. E., Islas, L. V., Kim, Y. K., Tran, L. M., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.04.022 · Cited by 465 · see citing works

Next-generation cancer organoids

LeSavage, B. L., Suhar, R. A., Broguière, N., Lütolf, M. P., & Heilshorn, S. C. (2021) · Nature Materials · doi:10.1038/s41563-021-01057-5 · Cited by 462 · see citing works

Pancreatic cancer organoids recapitulate disease and allow personalized drug screening

Driehuis, E., van Hoeck, A., Moore, K., Kolders, S., Francies, H. E., Gülersönmez, M. C., Stigter, E. C. A., Burgering, B. M. T., Geurts, V., Gracanin, A., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1911273116 · Cited by 460 · see citing works

Xenograft and organoid model systems in cancer research

Bleijs, M., van de Wetering, M., Clevers, H., & Drost, J. (2019) · The EMBO Journal · doi:10.15252/embj.2019101654 · Cited by 400 · see citing works

A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology

Guillen, K. P., Fujita, M., Butterfield, A. J., Scherer, S. D., Bailey, M. H., Chu, Z., DeRose, Y. S., Zhao, L., Cortes-Sanchez, E., Yang, C.-H., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00337-6 · Cited by 416 · see citing works

3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions

Rodrigues, J., Heinrich, M. A., Teixeira, L. M., & Prakash, J. (2021) · Trends in Cancer · doi:10.1016/j.trecan.2020.10.009 · Cited by 405 · see citing works

Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer

Huang, L., Rong, Y., Tang, X., Yi, K., Qi, P., Hou, J., Liu, W., He, Y. Z., Gao, X., Yuan, C., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01515-x · Cited by 413 · see citing works

Organoid Models of Tumor Immunology

Yuki, K., Cheng, N., Nakano, M., & Kuo, C. J. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.06.010 · Cited by 401 · see citing works

Glioblastoma Model Using Human Cerebral Organoids

Ogawa, J., Pao, G. M., Shokhirev, M. N., & Verma, I. M. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.105 · Cited by 391 · see citing works

Tumor microenvironment: barrier or opportunity towards effective cancer therapy

Tiwari, A., Trivedi, R., & Lin, S. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00866-3 · Cited by 391 · see citing works

Disease modelling in human organoids

Lancaster, M. A., & Huch, M. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.039347 · Cited by 379 · see citing works

Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer

Saatci, Ö., Kaymak, A., Raza, U., Ersan, P. G., Akbulut, Ö., Banister, C. E., Sikirzhytski, V., Tokat, Ü. M., Aykut, G., Ansari, S. A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16199-4 · Cited by 373 · see citing works

Organoids in immunological research

Bar-Ephraim, Y. E., Kretzschmar, K., & Clevers, H. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0248-y · Cited by 361 · see citing works

Fasting-mimicking diet and hormone therapy induce breast cancer regression

Caffa, I., Spagnolo, V., Vernieri, C., Valdemarin, F., Becherini, P., Wei, M., Brandhorst, S., Zucal, C., Driehuis, E., Ferrando, L., et al. (2020) · Nature · doi:10.1038/s41586-020-2502-7 · Cited by 360 · see citing works

3D model for CAR‐mediated cytotoxicity using patient‐derived colorectal cancer organoids

Schnalzger, T. E., de Groot, M. H., Zhang, C., Mosa, M. H., Michels, B. E., Röder, J., Darvishi, T., Wels, W. S., & Farin, H. F. (2019) · The EMBO Journal · doi:10.15252/embj.2018100928 · Cited by 354 · see citing works

Organoid technology and applications in cancer research

Xu, H., Lyu, X., Yi, M., Zhao, W., Song, Y., & Wu, K. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0662-9 · Cited by 350 · see citing works

Tumor organoids: Opportunities and challenges to guide precision medicine

Veninga, V., & Voest, E. E. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.07.020 · Cited by 339 · see citing works

Comprehensive metabolomics expands precision medicine for triple-negative breast cancer

Xiao, Y., Ma, D., Yang, Y., Yang, F., Ding, J.-H., Gong, Y., Jiang, L., Ge, L., Wu, S., Yu, Q., et al. (2022) · Cell Research · doi:10.1038/s41422-022-00614-0 · Cited by 330 · see citing works

Human disease models in drug development

Loewa, A., Feng, J. J., & Hedtrich, S. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00063-3 · Cited by 331 · see citing works

Patient-derived organoids as a predictive biomarker for treatment response in cancer patients

Wensink, G. E., Elias, S. G., Mullenders, J., Koopman, M., Boj, S. F., Kranenburg, O. W., & Roodhart, J. M. L. (2021) · npj Precision Oncology · doi:10.1038/s41698-021-00168-1 · Cited by 323 · see citing works

Detecting the mutational signature of homologous recombination deficiency in clinical samples

Gulhan, D., Lee, J. J.-K., Melloni, G. E. M., Cortés‐Ciriano, I., & Park, P. J. (2019) · Nature Genetics · doi:10.1038/s41588-019-0390-2 · Cited by 316 · see citing works

Organoid Cultures as Preclinical Models of Non–Small Cell Lung Cancer

Shi, R., Radulovich, N., Ng, C., Liu, N., Notsuda, H., Cabanero, M., Martins-Filho, S. N., Raghavan, V., Li, Q., Mer, A. S., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1376 · Cited by 316 · see citing works

Precision Medicine: Disease Subtyping and Tailored Treatment

Wang, R. C., & Wang, Z. (2023) · Cancers · doi:10.3390/cancers15153837 · Cited by 337 · see citing works

Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment

Polak, R., Zhang, E., & Kuo, C. J. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00706-6 · Cited by 322 · see citing works

GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer

Wu, Q., Ba-Alawi, W., Deblois, G., Cruickshank, J., Duan, S., Lima‐Fernandes, E., Haight, J., Tonekaboni, S. A. M., Fortier, A.-M., Kuasne, H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18020-8 · Cited by 304 · see citing works

An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity

Calandrini, C., Schutgens, F., Oka, R., Margaritis, T., Candelli, T., Mathijsen, L., Ammerlaan, C. M. E., van Ineveld, R. L., Derakhshan, S., de Haan, S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15155-6 · Cited by 304 · see citing works

Platinum Resistance in Ovarian Cancer: Role of DNA Repair

Damia, G. L. M., & Broggini, M. (2019) · Cancers · doi:10.3390/cancers11010119 · Cited by 297 · see citing works

Three-dimensional bioprinted glioblastoma microenvironments model cellular dependencies and immune interactions

Tang, M., Xie, Q., Gimple, R. C., Zhong, Z., Tam, T., Tian, J., Kidwell, R. L., Wu, Q., Prager, B. C., Qiu, Z., et al. (2020) · Cell Research · doi:10.1038/s41422-020-0338-1 · Cited by 298 · see citing works

Volumetric Bioprinting of Organoids and Optically Tuned Hydrogels to Build Liver‐Like Metabolic Biofactories

Bernal, P. N., Bouwmeester, M., Madrid-Wolff, J. A., Falandt, M., Florczak, S., Rodriguez, N. G., Li, Y., Größbacher, G., Samsom, R., van Wolferen, M. E., et al. (2022) · Advanced Materials · doi:10.1002/adma.202110054 · Cited by 290 · see citing works

Growth of Epithelial Organoids in a Defined Hydrogel

Broguiere, N., Isenmann, L., Hirt, C., Ringel, T., Placzek, S., Cavalli, E., Ringnalda, F., Villiger, L., Züllig, R., Lehmann, R., et al. (2018) · Advanced Materials · doi:10.1002/adma.201801621 · Cited by 282 · see citing works

Mouse and human urothelial cancer organoids: A tool for bladder cancer research

Mullenders, J., de Jongh, E., Brousali, A., Roosen, M. M., Blom, J. P. A., Begthel, H., Korving, J., Jonges, T. G. N., Kranenburg, O., Meijer, R. P., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1803595116 · Cited by 280 · see citing works

Could 3D models of cancer enhance drug screening?

Brancato, V., Oliveira, J. M., Correlo, V. M., Reis, R. L., & Kundu, S. C. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119744 · Cited by 283 · see citing works

Organoid cultures from normal and cancer-prone human breast tissues preserve complex epithelial lineages

Rosenbluth, J. M., Schackmann, R. C. J., Gray, G. K., Selfors, L. M., Li, C. M.-C., Boedicker, M., Kuiken, H. J., Richardson, A. L., Brock, J. E., Garber, J. E., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15548-7 · Cited by 277 · see citing works

Tumor organoids: applications in cancer modeling and potentials in precision medicine

Xu, H., Jiao, D., Liu, A., & Wu, K. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01278-4 · Cited by 286 · see citing works

Personalized Cancer Medicine: An Organoid Approach

Es, H. A., Montazeri, L., Aref, A. R., Vosough, M., & Baharvand, H. (2018) · Trends in biotechnology · doi:10.1016/j.tibtech.2017.12.005 · Cited by 277 · see citing works

Long-term culture, genetic manipulation and xenotransplantation of human normal and breast cancer organoids

Dekkers, J. F., van Vliet, E. J., Sachs, N., Rosenbluth, J. M., Kopper, O., Rebel, H. G., Wehrens, E. J., Piani, C., Visvader, J. E., Veríssimo, C. S., et al. (2021) · Nature Protocols · doi:10.1038/s41596-020-00474-1 · Cited by 268 · see citing works

Three-dimensional in vitro culture models in oncology research

Jubelin, C., Muñoz-García, J., Griscom, L., Cochonneau, D., Ollivier, E., Heymann, M., Vallette, F. M., Oliver, L., & Heymann, D. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00887-3 · Cited by 280 · see citing works

Lung cancer organoids analyzed on microwell arrays predict drug responses of patients within a week

Hu, Y., Sui, X., Song, F., Li, Y., Li, K., Chen, Z., Yang, F., Chen, X., Zhang, Y., Wang, X., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22676-1 · Cited by 272 · see citing works

Organoids: The current status and biomedical applications

Yang, S., Hu, H., Kung, H., Zou, R.-Q., Dai, Y.-S., Hu, Y.-F., Wang, T., Lv, T., Yu, J., & Li, F. (2023) · MedComm · doi:10.1002/mco2.274 · Cited by 282 · see citing works

Modeling neoplastic disease with spheroids and organoids

Zanoni, M., Cortesi, M., Zamagni, A., Arienti, C., Pignatta, S., & Tesei, A. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00931-0 · Cited by 265 · see citing works

3D microfluidic <i>ex vivo</i> culture of organotypic tumor spheroids to model immune checkpoint blockade

Aref, A. R., Campisi, M., Ivanova, E., Portell, A., Larios, D., Piel, B. P., Mathur, N., Zhou, C., Coakley, R. V., Bartels, A., et al. (2018) · Lab on a Chip · doi:10.1039/c8lc00322j · Cited by 265 · see citing works

Targeted therapy for head and neck cancer: signaling pathways and clinical studies

Li, Q., Tie, Y., Alu, A., Ma, X., & Shi, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01297-0 · Cited by 269 · see citing works

Ongoing chromosomal instability and karyotype evolution in human colorectal cancer organoids

Bolhaqueiro, A. C. F., Ponsioen, B., Bakker, B., Klaasen, S. J., Küçükköse, E., van Jaarsveld, R. H., Vivié, J., Verlaan-Klink, I., Hami, N., Spierings, D. C. J., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0399-6 · Cited by 240 · see citing works

Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma

Zhang, S., Dolgalev, I., Zhang, T., Ran, H., Levine, D. A., & Neel, B. G. (2019) · Nature Communications · doi:10.1038/s41467-019-13116-2 · Cited by 235 · see citing works

Patient-derived micro-organospheres enable clinical precision oncology

Ding, S., Hsu, C., Wang, Z., Natesh, N. R., Millen, R., Negrete, M., Giroux, N., Rivera, G. O., Dohlman, A., Bose, S., et al. (2022) · Cell Stem Cell · doi:10.1016/j.stem.2022.04.006 · Cited by 228 · see citing works

Uncovering the mode of action of engineered T cells in patient cancer organoids

Dekkers, J. F., Alieva, M., Cleven, A., Keramati, F., Wezenaar, A. K. L., van Vliet, E. J., Puschhof, J., Brázda, P., Johanna, I., Meringa, A. D., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01397-w · Cited by 232 · see citing works

A PDX/Organoid Biobank of Advanced Prostate Cancers Captures Genomic and Phenotypic Heterogeneity for Disease Modeling and Therapeutic Screening

Beshiri, M. L., Tice, C. M., Tran, C., Nguyen, H. M., Sowalsky, A. G., Agarwal, S., Jansson, K. H., Yang, Q., McGowen, K. M., Yin, J., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0409 · Cited by 228 · see citing works

Basic principles of biobanking: from biological samples to precision medicine for patients

Annaratone, L., Palma, G. D., Bonizzi, G., Sapino, A., Botti, G., Berrino, E., Mannelli, C., Arcella, P., Martino, S. D., Steffan, A., et al. (2021) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-021-03151-0 · Cited by 227 · see citing works

Application of Cancer Organoid Model for Drug Screening and Personalized Therapy

Kondo, J., & Inoue, M. (2019) · Cells · doi:10.3390/cells8050470 · Cited by 224 · see citing works

N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer

Zou, Y., Zheng, S., Xie, X., Ye, F., Hu, X., Tian, Z., Yang, L., Yang, L., Tang, Y., Tang, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30217-7 · Cited by 227 · see citing works

Genomic evolution of cancer models: perils and opportunities

Ben‐David, U., Beroukhim, R., & Golub, T. R. (2018) · Nature reviews. Cancer · doi:10.1038/s41568-018-0095-3 · Cited by 220 · see citing works

Patient-derived explants (PDEs) as a powerful preclinical platform for anti-cancer drug and biomarker discovery

Powley, I. R., Patel, M., Miles, G. J., Pringle, H., Howells, L. M., Thomas, A., Kettleborough, C. A., Bryans, J. S., Hammonds, T. R., MacFarlane, M., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-019-0672-6 · Cited by 221 · see citing works

Bioengineering Approaches for the Advanced Organoid Research

Yi, S. A., Zhang, Y., Rathnam, C., Pongkulapa, T., & Lee, K. (2021) · Advanced Materials · doi:10.1002/adma.202007949 · Cited by 218 · see citing works

Probing the Tumor Suppressor Function of BAP1 in CRISPR-Engineered Human Liver Organoids

Artegiani, B., van Voorthuijsen, L., Lindeboom, R. G. H., Seinstra, D., Heo, I., Tapia, P., López-Iglesias, C., Postrach, D., Dayton, T., Oka, R., et al. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.04.017 · Cited by 218 · see citing works

Generation and biobanking of patient-derived glioblastoma organoids and their application in CAR T cell testing

Jacob, F., Ming, G., & Song, H. (2020) · Nature Protocols · doi:10.1038/s41596-020-0402-9 · Cited by 216 · see citing works

Patient-derived tumor organoids: a new avenue for preclinical research and precision medicine in oncology

Thorel, L., Perréard, M., Florent, R., Divoux, J., Coffy, S., Vincent, A., Gaggioli, C., Guasch, G., Gidrol, X., Weiswald, L., et al. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01272-5 · Cited by 228 · see citing works

Organ-on-a-Chip for Cancer and Immune Organs Modeling

Sun, W., Luo, Z., Lee, J., Kim, H., Lee, K., Tebon, P., Feng, Y., Dokmeci, M. R., Sengupta, S., & Khademhosseini, A. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201801363 · Cited by 221 · see citing works

Breast Cancer: A Molecularly Heterogenous Disease Needing Subtype-Specific Treatments

Testa, U., Castelli, G., & Pelosi, E. (2020) · Medical Sciences · doi:10.3390/medsci8010018 · Cited by 226 · see citing works

Clinical applications of human organoids

Verstegen, M. M. A., Coppes, R. P., Béghin, A., Coppi, P. D., Gerli, M., de Graeff, N., Pan, Q., Saito, Y., Shi, S., ZADPOOR, A. A., et al. (2025) · Nature Medicine · doi:10.1038/s41591-024-03489-3 · Cited by 228 · see citing works

AI-enabled organoids: Construction, analysis, and application

Bai, L., Wu, Y., Li, G., Zhang, W., Zhang, H., & Su, J. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.09.005 · Cited by 216 · see citing works

A Pharmacogenomic Landscape in Human Liver Cancers

Qiu, Z., Li, H., Zhang, Z., Zhu, Z., He, S., Wang, X., Wang, P., Qin, J., Zhuang, L., Wang, W., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.07.001 · Cited by 202 · see citing works

Patient‐Derived Organoids Can Guide Personalized‐Therapies for Patients with Advanced Breast Cancer

Chen, P., Zhang, X., Ding, R., Yang, L., Lyu, X., Zeng, J., Lei, J. H., Wang, L., Bi, J., Shao, N., et al. (2021) · Advanced Science · doi:10.1002/advs.202101176 · Cited by 207 · see citing works

DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine

Yu, J., Qin, B., Moyer, A. M., Nowsheen, S., Liu, T., Qin, S., Zhuang, Y., Liu, D., Lu, W., Kalari, K. R., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97924 · Cited by 203 · see citing works

Patient‐Derived Organoids from Colorectal Cancer with Paired Liver Metastasis Reveal Tumor Heterogeneity and Predict Response to Chemotherapy

Mo, S., Tang, P., Luo, W., Zhang, L., Li, Y., Hu, X., Ma, X., Chen, Y., Bao, Y., He, X., et al. (2022) · Advanced Science · doi:10.1002/advs.202204097 · Cited by 198 · see citing works

Emerging organoid models: leaping forward in cancer research

Fan, H., Demirci, U., & Chen, P. (2019) · Journal of Hematology &amp; Oncology · doi:10.1186/s13045-019-0832-4 · Cited by 199 · see citing works

Signaling in the stem cell niche: regulating cell fate, function and plasticity

Chacón‐Martínez, C. A., Koester, J., & Wickström, S. A. (2018) · Development · doi:10.1242/dev.165399 · Cited by 193 · see citing works

Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study

Wang, H.-M., Zhang, C.-Y., Peng, K., Chen, Z.-X., Su, J., Li, Y., Li, W., Gao, Q.-Y., Zhang, S., Chen, Y., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100911 · Cited by 204 · see citing works

Developing Organoids from Ovarian Cancer as Experimental and Preclinical Models

Maenhoudt, N., Defraye, C., Boretto, M., Jan, Z., Heremans, R., Boeckx, B., Hermans, F., Arijs, I., Cox, B., Van Nieuwenhuysen, E., et al. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.03.004 · Cited by 186 · see citing works

Organoid models of gastrointestinal cancers in basic and translational research

Lau, H. C.-H., Kranenburg, O., Xiao, H., & Yu, J. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0255-2 · Cited by 195 · see citing works

Cell Model Passports-a hub for clinical, genetic and functional datasets of preclinical cancer models

van der Meer, D., Barthorpe, S., Yang, W., Lightfoot, H., Hall, C., Gilbert, J., Francies, H. E., & Garnett, M. J. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky872 · Cited by 195 · see citing works

Use and application of 3D-organoid technology

Artegiani, B., & Clevers, H. C. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy187 · Cited by 190 · see citing works

Intelligent Microfluidics: The Convergence of Machine Learning and Microfluidics in Materials Science and Biomedicine

Galan, E. A., Zhao, H., Wang, X., Dai, Q., Huck, W. T. S., & Ma, S. (2020) · Matter · doi:10.1016/j.matt.2020.08.034 · Cited by 192 · see citing works

Applications of organoids for cancer biology and precision medicine

Lo, Y.-H., Karlsson, K., & Kuo, C. J. (2020) · Nature Cancer · doi:10.1038/s43018-020-0102-y · Cited by 182 · see citing works

ESR1 mutations and therapeutic resistance in metastatic breast cancer: progress and remaining challenges

Herzog, S. K., & Fuqua, S. A. W. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01564-x · Cited by 192 · see citing works

Promises and challenges of organoid-guided precision medicine

Bose, S., Clevers, H., & Shen, X. (2021) · Med · doi:10.1016/j.medj.2021.08.005 · Cited by 213 · see citing works

Modeling Breast Cancer Using CRISPR-Cas9–Mediated Engineering of Human Breast Organoids

Dekkers, J. F., Whittle, J. R., Vaillant, F., Chen, H., Dawson, C. A., Liu, K., Geurts, M. H., Herold, M. J., Clevers, H. C., Lindeman, G. J., et al. (2019) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djz196 · Cited by 186 · see citing works

Abstract ES10-2: A novel human derived organoid platform for breast cancer research

Kopper, O. (2018) · Cancer Research · doi:10.1158/1538-7445.sabcs17-es10-2

Biobanking breast cancers

(2018) · Nature Methods · doi:10.1038/nmeth.4591 · Cited by 1 · see citing works

Advances in breast cancer organoid for individualized treatment

Li, X., & Zhu, D. (2023) · Organs-on-a-Chip · doi:10.1016/j.ooc.2023.100028 · Cited by 5 · see citing works

Optimizing individualized treatment strategy based on breast cancer organoid model

Pan, B., Li, X., Zhao, D., et al. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.380 · Cited by 20 · see citing works

Breast cancer organoids: a precision platform for modeling heterogeneity and advancing personalized therapy

Yang, Y., Yang, J., Liang, Y., & Yang, Q. (2026) · Molecular and Digital Medicine · doi:10.1016/j.mdmed.2026.100004